ArticleFrontiers in pharmacology2022

Genetically proxied inhibition of tumor necrosis factor and the risk of colorectal cancer: A drug-target mendelian randomization study.

Min Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.